A detailed history of Black Rock Inc. transactions in Zynex Inc stock. As of the latest transaction made, Black Rock Inc. holds 1,334,887 shares of ZYXI stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,334,887
Previous 1,449,702 7.92%
Holding current value
$12.4 Million
Previous $15.8 Million 4.59%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$9.86 - $13.74 $1.13 Million - $1.58 Million
-114,815 Reduced 7.92%
1,334,887 $16.5 Million
Q4 2023

Feb 13, 2024

SELL
$7.1 - $10.89 $199,794 - $306,444
-28,140 Reduced 1.9%
1,449,702 $15.8 Million
Q3 2023

Nov 13, 2023

SELL
$6.95 - $9.89 $12.3 Million - $17.5 Million
-1,765,354 Reduced 54.43%
1,477,842 $11.8 Million
Q2 2023

Aug 11, 2023

SELL
$8.59 - $14.56 $1.37 Million - $2.32 Million
-159,153 Reduced 4.68%
3,243,196 $31.1 Million
Q1 2023

May 12, 2023

BUY
$9.53 - $16.8 $54,483 - $96,045
5,717 Added 0.17%
3,402,349 $40.8 Million
Q4 2022

Feb 13, 2023

SELL
$8.71 - $14.28 $657,535 - $1.08 Million
-75,492 Reduced 2.17%
3,396,632 $47.2 Million
Q3 2022

Nov 14, 2022

BUY
$7.19 - $9.91 $288,347 - $397,430
40,104 Added 1.17%
3,472,124 $31.5 Million
Q2 2022

Aug 12, 2022

BUY
$5.78 - $8.87 $69,984 - $107,397
12,108 Added 0.35%
3,432,020 $27.4 Million
Q1 2022

May 12, 2022

BUY
$5.14 - $9.35 $1.98 Million - $3.6 Million
384,548 Added 12.67%
3,419,912 $21.3 Million
Q4 2021

Feb 10, 2022

BUY
$8.71 - $13.77 $213,995 - $338,315
24,569 Added 0.82%
3,035,364 $30.3 Million
Q3 2021

Nov 09, 2021

BUY
$10.35 - $15.65 $284,945 - $430,860
27,531 Added 0.92%
3,010,795 $34.3 Million
Q2 2021

Aug 11, 2021

BUY
$12.25 - $14.87 $36.5 Million - $44.4 Million
2,983,264 New
2,983,264 $46.3 Million

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $349M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.